Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)Tax Rate
Others
Ratios

NewGenIvf (NIVF) Net Income towards Common Stockholders: 2024-2025

Historic Net Income towards Common Stockholders for NewGenIvf (NIVF) over the last 2 years, with Sep 2025 value amounting to $16.7 million.

  • NewGenIvf's Net Income towards Common Stockholders rose 55297.35% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 million, marking a year-over-year change of. This contributed to the annual value of -$474,101 for FY2024, which is 537.29% down from last year.
  • NewGenIvf's Net Income towards Common Stockholders amounted to $16.7 million in Q3 2025, which was up 3,186.14% from -$542,684 recorded in Q4 2024.
  • In the past 5 years, NewGenIvf's Net Income towards Common Stockholders ranged from a high of $16.7 million in Q3 2025 and a low of -$542,684 during Q4 2024.